-
Guizhou Province to accelerate the development of new building materials industry to promote the General Assembly held
Time of Update: 2021-01-23
bottom lines of development and ecology, adhere to the guidance of energy conservation, environmental protection and low carbon, dig deep into the "new" connotation, do a good job of "green" articles, pay close attention to major projects, cultivate
-
Eur J Cancer: Effects of BRCA1/2 mutations on the risk of severe blood toxicity during new complementary chemotherapy for triple negative breast cancer
Time of Update: 2021-01-23
in patients with gBRCA1/2 mutations may have a higher risk of developing GIII-IV blood toxicity under yew alcohol therapy and require further study.
-
Seven trends in the global biopharmaceutical industry are forecast for 2021 under the new crown outbreak
Time of Update: 2021-01-23
therapy developer, for $280 million, and Roche signed a $1.8 billion contract with Dyno Therapeutics to use the latter's technology platform to develop adenovirus (AAV) vectors for gene therapy for central nervous system (CNS) disease and liver
-
Focus on the JPM | Wanchun's new ascending white drug Punabrin PHASE III clinical end point
Time of Update: 2021-01-23
Punabrin, with its unique mechanism of action, is able to quickly protect neutral granulocytes in the first 8 days, complementing G-CSF co-use time and significantly reducing the full-cycle severe CIN rate caused by chemotherapy in patients with non-myelin cancer.
-
TAVO in combination with OPDIVO as a new complementary therapy for melanoma: the first time a patient has been given a drug in a Phase II trial
Time of Update: 2021-01-23
clinical results have been shown when opdivo (nivolumab), an anti-PD1 checkpoint inhibitor, is used as a new complementary therapy, rapid recurrence remains a problem for many patients.
-
Clin Cancer Res: ST6GAL1, a new serum biomarker for liver cancer driven by Levardinib's susceptible FGF19!
Time of Update: 2021-01-23
for patients with high serum ST6GAL1 levels of liver cancer treated with TKI, the survival rate of levatinib treatment was significantly higher than that of soraphinib.
-
Health and Safety Commission new rules: from next month, doctors buckled 18 separation posts
Time of Update: 2021-01-23
not write medical records withheld 10 points about the writing of medical records is not standardized this point in the primary medical institutions is more serious, such as dosage form, dose, use is not clear, the reorientation of medical advice did
-
The first FDA in 2021 today approved the launch of a new Bayer/Merca East heart failure drug
Time of Update: 2021-01-23
median follow-up period of 10.8 months showed that the Verquvo treatment group reduced the risk of compound endpoint death from heart failure (35.5% vs 38.5%, HR-0.90, P-0.02) compared to the placebo group.
-
New mechanisms for cancer cells to evade host immune defenses: or hopefully help develop new cancer therapies
Time of Update: 2021-01-23
We all know that cancer cells are known for spreading genetic confusion, and as cancer cells divide, DNA fragments and even entire chromosomes can repeat, mutate, or become completely missing; they say the more unstable the chromosomes
-
New hope has been expressed for patients with ALK-positive non-small cell lung cancer
Time of Update: 2021-01-23
Crizotinib Xalkori, a competitive multi-target protein kinase inhibitor developed by Pfizer to inhibit Met, ALK, and ROS, was approved by the FDA for the treatment of ALK-positive late/metastasis NSCLC (2011/08) and ROS1-positive late/metastasis NSCLC (2016/03).
-
German biopicists have discovered new weaknesses in the new coronavirus
Time of Update: 2021-01-23
of Tybingen who has been working on the new coronavirus since January 2020, is responsible for computer-based systems biology, focusing on optimizing the development and progression of diseases at the biotechnology and molecular levels. They have
-
China has discovered the new genus of the American Mole, the Mole
Time of Update: 2021-01-23
, the new genus of the American Mole, the new species - the mountain Mole belongs to the Mole. It is the highest known distribution altitude of the American Mole. The American Mole belongs to the Lactation Gang Mole Section, and now has a total of 4
-
New coatings solve the problem of road ice
Time of Update: 2021-01-23
it is known that this new road de-icing coating material, in winter snow and ice weather, the road surface with it will not freeze.
-
2020 inventory: FDA and EMA approve peak sales forecast for new drugs!
Time of Update: 2021-01-23
April, Immunomedics' antibody drug binding (ADC) Trodelvy (sacituzumab-govitecan-hziy) was approved by the FDA for adult patients with metastassic trisomy breast cancer who had previously received at least two treatments.
-
In 2020, the United States approved new treatments for these rare diseases
Time of Update: 2021-01-23
the listing of C5 supplement inhibitor Ecolizumab (Soliris) to treat AQP4 antibody-positive adult NMOSD patients. is the first new drug approved for treatment in the field of NMOSD. June this year, the anti-CD19 monoclonal antibody Uplizna
-
What are the new trends in protein degradation in the past year?
Time of Update: 2021-01-23
article, Cullgen developed two new TRK-targeted protein degradation agents: CG416 and CG428, designed to address side effects and drug resistance in patients taking TRK inhibitors.
-
CAR-T therapy's new partner, STING astrists
Time of Update: 2021-01-23
Source: Medical Rubik's Cube Pro CAR-T therapies like Novarma's Kymriah and Gilead's Yescarta have changed the fortunes of some leukemia and lymphoma patients, but how to apply this technique to physical tumors is a challenge. Immune pathline
-
U.S. Cancer Statistics 2021: 1.89 million new cases and 600,000 deaths, the second year in a row that the death rate has dropped sharply
Time of Update: 2021-01-23
women have a higher rate of non-smoking-related lung cancer than men, smoking remains the leading preventable cause of death in the United States, costing more than $300 billion a year.
-
The new crown vaccination can take effect about 14 days after two injections
Time of Update: 2021-01-23
, nausea, headache, muscle aches, etc., generally do not need to be treated, 2-3 days after most can recover on their own. has not yet been monitored for serious adverse vaccine-related reactions. ," Lurie said. 14 days after
-
Showing the potential for asymptomatic infection FDA releases detailed data on Moderna's new crown vaccine
Time of Update: 2021-01-23
participants before the first vaccination and before the second vaccination and assessed whether the samples carried the new coronavirus. descriptive summary showed that among participants who tested negative for neo-coronavirus nucleic acid
